Company Pandion Therapeutics, Inc.
Equities
PAND
US6983401067
Biotechnology & Medical Research
Business Summary
Number of employees: 56
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gregg Beloff
DFI | Director of Finance/CFO | 56 | - |
Chief Tech/Sci/R&D Officer | - | 01/17/01 | |
Edward Freedman
COO | Chief Operating Officer | 55 | - |
Michelle Avery
IRC | Investor Relations Contact | - | 01/20/01 |
Anthony Mullin
HRO | Human Resources Officer | - | - |
Kevin Otipoby
PRN | Corporate Officer/Principal | - | - |
Vikas Goyal
PRN | Corporate Officer/Principal | 45 | 01/19/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,515,583 | 21,998,484 ( 74.53 %) | 0 | 74.53 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-1.43% | 103B | |
+8.96% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.04% | 16.94B | |
+6.79% | 14.07B | |
+38.61% | 12.35B |